Bs 6121 Part 1 1989 Pdf 18
Wade Hendryx
Objectives: To study selected aspects of the physical environment which directly affect people and their buildings, such as climate, weather, solar radiation and heat gain and loss. To Study the means by which environmental factors may be wisely utilized, controlled and modified as an integral part of the architectural design.
Content: 6121 will undertake the study of human needs, comfort, performance and sense of well being in relation to the physical environments both natural and man made which occur in and around buildings. Recent environmental problems have been traced to the energy and waste products used or created by buildings. These environmental problems make it imperative that architects be familiar with the systems that affect building energy use. Students in this course will become familiar with those elements of a building that contribute to the heat and cooling loads in the building and will be introduced to methods that reduce the energy consumption. Different methods of analysis, evaluation and simulation will be introduced and used.
Under 5 U.S.C. 6121(5), a compressed work schedule means that an employee's basic work requirement for each pay period is scheduled (by the agency) for less than 10 workdays. See the definition and requirements for regularly scheduled work in 5 CFR 610.102 and 5 CFR 610.111(d).
Under subchapter II of chapter 61 of title 5, United States Code, AWS programs may apply to employees of any executive agency (excluding the U.S. Postal Service), any military department, the Government Printing Office, or the Library of Congress.
If the head of an agency finds that a particular AWS schedule has had an "adverse agency impact," the agency must promptly determine not to continue the schedule ( 5 U.S.C. 6131(a)(2)). If establishment of the AWS schedule was negotiated, the agency may reopen the agreement to seek its termination ( 5 U.S.C. 6131(c)(3)). If an impasse results, the dispute goes to the Federal Service Impasses Panel, which will determine within 60 days whether the agency's determination is supported by evidence. If it is, the Panel must act in favor of the agency. See 5 U.S.C. 6131(c)(3)(B) and (C). The AWS schedule may not be terminated until agreement is reached or the Panel acts. (See 5 U.S.C. 6106 and 6131(a)(3)(D).)
Night differential will not be paid solely because a prevailing rate employee elects to work credit hours, or elects a time of arrival or departure at a time of day when night differential is otherwise authorized, except that prevailing rate employees are entitled to night differential for regularly scheduled nonovertime work when a majority of the hours of a FWS schedule for a daily tour of duty occur during the night. (See 5 U.S.C. 5343(f) and 6123(c)(2).)
The tour of duty for employees under a CWS program is defined by a fixed schedule established by the agency. See the definition of "compressed schedule" in 5 U.S.C. 6121(5), which states that the basic work requirement is scheduled for less than 10 work days. Also, see the definition of "regularly scheduled" in 5 CFR 610.102.
Compressed work schedules are arranged to enable employees to fulfill their basic work requirements in less than 10 days during the biweekly pay period. (Examples of these schedules may be found in Appendix C.) Although agencies may change or stagger the arrival and departure times of employees, there are no provisions for employee flexibility in reporting or quitting times under a CWS program.
Compressed work schedules are always fixed schedules. (See B-179810, Comptroller General's Report to the House Subcommittee on Compensation and Employee Benefits, Committee on Post Office and Civil Service, pg. 2, footnote 1, December 4, 1979. Also, see the definition of "compressed schedule" in 5 U.S.C. 6121(5) and 50 FLRA No. 28, February 23, 1995. )
For a full-time employee under a CWS program who is exempt from the FLSA, overtime hours are all officially ordered and approved hours of work in excess of the compressed work schedule. For a full-time employee who is covered by the FLSA (non-exempt), overtime hours also include any hours worked outside the compressed work schedule that are "suffered or permitted." For a part-time employee, overtime hours are hours in excess of the compressed work schedule for a day (but must be more than 8 hours) or for a week (but must be more than 40 hours).
The Code of Federal Regulations (CFR) is the official legal print publication containing the codification of the general and permanent rules published in the Federal Register by the departments and agencies of the Federal Government. The Electronic Code of Federal Regulations (eCFR) is a continuously updated online version of the CFR. It is not an official legal edition of the CFR.
This subpart applies to each employee to whom subpart A of part 550 applies and to each employee whose pay is fixed and adjusted from time to time under section 5343 or 5349 of title 5, United States Code, or by a wage board or similar administrative authority serving the same purpose.
The purpose of this subpart is to provide uniform and equitable standards under which regular employees paid at daily, hourly, or piecework rates may be relieved from duty with pay by administrative order.
The authority in this subpart may be used only to the extent warranted by good administration for short periods of time not generally exceeding 3 consecutive work days in a single period of excused absence. This authority may not be used in situations of extensive duration or for periods of interrupted or suspended operations such as ordinarily would be covered by the scheduling of leave, furlough, or the assignment of other work. Insofar as practicable, each administrative order issued under this subpart shall provide benefits for regular employees paid at daily, hourly, or piecework rates similar to those provided for employees paid at annual rates.
This subpart contains regulatory requirements prescribed by the Office of Personnel Management to implement certain provisions of subchapter 11 of chapter 61 of title 5, United States Code. These regulations supplement that subchapter and must be read together with it.
An agency that authorizes a flexible work schedule or a compressed work schedule under this subpart shall establish a time-accounting method that will provide affirmative evidence that each employee subject to the schedule has worked the proper number of hours in a biweekly pay period.
If a part-time employee is relieved or prevented from working on a day within the employee's scheduled tour of duty that is designated as a holiday by Federal statute or Executive order, the employee is entitled to basic pay with respect to the holiday for the number of hours the employee is scheduled to work on that day, not to exceed 8 hours. When a holiday falls on a nonworkday of a part-time employee, he or she is not entitled to an in-lieu-of day for that holiday.
MV is professor and until August 1st, 2018 the head of the Department of Radiation Oncology at The Netherlands Cancer Institute, Amsterdam, The Netherlands, and currently head of the Department of Radiation Oncology at Radboud University Medical Center, Nijmegen, The Netherlands. MvdH is professor and head of the Department of Lung Diseases at Radboud University Medical Center, Nijmegen, The Netherlands. MvdB is professor and head and neck surgeon. CV is radiobiologist. JS is professor and until July 1st, 2018 the head of the Department of Clinical Pharmacology at The Netherlands Cancer Institute, Amsterdam, The Netherlands. HP is dedicated lung radiation oncologist, PE is dedicated breast cancer radiation oncologist. GS is dedicated breast cancer medical oncologist, MT is dedicated HNSCC medical oncologist and AA is dedicated HNSCC radiation oncologist. EvW is statistician. RdH is resident in radiation oncology and PhD student. BvT is radiation oncologist with a special interest in the development of radiosensitisers. All authors worked at The Netherlands Cancer Institute, Amsterdam, The Netherlands at the time of the design of the three study protocol described in this article.
All studies will be performed compliant with current standards of ICH GCP, the WHO Declaration of Helsinki and in accordance with the Medical Research Involving Human Subjects Act (WMO). The study protocols of all three trials are approved by the METC (Medisch-Ethische Toetsingscommissie, medical ethics committee) of The Netherlands Cancer Institute, Amsterdam, The Netherlands. All past and future protocol modifications are, or will be, submitted as amendments to the METC for approval. Most recent approved protocol versions are: version 6.0 dated June 23, 2014 for the NSCLC trial, version 6.0 dated March 08, 2017 for the breast cancer trial, and version 5.0 dated March 28, 2018 for the HNSCC trial. Patients receive both oral and written information on the study from their treating physician. Written informed consent is obtained before any study procedures. An optional part in the breast cancer trial and HNSCC trial involves genetic analysis. For patients that choose to take part of this analysis, there is a possibility of detection of unsolicited findings, i.e. germline DNA variants that confer an increased risk of developing malignancies or other diseases for both the patient and his/her family. Patients are informed about this possibility, and will be offered genetic counseling in case of revelation of a variant which is clinically relevant. A separate patient information file and consent form is used for this optional part of the study. Genetic analysis will only be performed in patients that give consent to performing genetic analysis AND to being informed on any unsolicited findings with clinical significance that have direct consequences for treatment or that are directly actionable (e.g. pathogenic mutations in BRCA1/2 genes). Patients can choose to be informed on unsolicited findings with clinical significance that are not directly actionable (e.g. carrier of an autosomal recessive disease). The complete study team at The Netherlands Cancer Institute will have access to the final trial dataset. The Netherlands Cancer Institute has a liability insurance that provides cover for damage to research subjects through injury or death as a result of participation in either one of the described studies. Trial results will be published in a major, peer-reviewed journal. Co-authors will include members of the protocol writing committee and physicians that have a substantial contribution in the conduct of the trial. AstraZeneca will be provided draft copies of all publications to review one month before submission. ClinicalTrials.gov registration was done on March 23, 2012 for the NSCLC trial, on August 27, 2014 for the breast cancer trial, and on September 1, 2014 for the HNSCC trial. The first patient was enrolled at June 06, 2012 in the NSCLC trial, at October 21, 2013 in the breast cancer trial, and at September 09, 2014 in the HNSCC trial. All three trials are currently ongoing. Secondary identifying trial numbers are:
dd2b598166